HTG Names Renowned RNA Expert Dr. Robert Spitale to Therapeutics Scientific Advisory Board

TUCSON, Ariz. , Feb. 03, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced it has appointed Robert Spitale , Ph.D., Associate Director and